Medipharm Labs Corp MEDIF

Primary Symbol: T.LABS

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > LABS has no Debt now and $13 Million in Cash.Time to Grow :)

<< Previous

Bullboard Posts

Next >>

Post by 1hot-techwomanon Nov 19, 2024 7:22am

164 Views

Post# 36319305

LABS has no Debt now and $13 Million in Cash.Time to Grow :)

“Q3 2024 was a major step in the right direction towards profitability," said CFO Greg Hunter. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while growing our higher margin international revenues are all critical elements to position us for long-term sustainable growth."

https://www.benzinga.com/news/earnings/24/11/41974843/cbd-pharma-co-medipharm-37-increase-in-q3-international-sales-15-yoy-revenue-growth

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project